12:00 AM
Apr 13, 2009
 |  BC Week In Review  |  Company News  |  Deals

Nuvera, J&J deal

Johnson & Johnson's Veridex LLC received a license to develop and commercialize Nuvera's diagnostic assays to predict patient response to tamoxifen...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >